Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 91
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04177212 | Investigation of the Effectiveness and Safety of MRZF111 in the Treatment of Décolleté Wrinkles | ||
| NCT04075981 | Prevention Atrial Fibrillation by BOTulinum Toxin Injections (BOTAF) | ||
| NCT00541905 | Daily Dystonia Practice - A Trial to Investigate NT 201, the Duration of Treatment Effect After One Injection Session and in Long-term Treatment in Cervical Dystonia | ||
| NCT02577224 | An RCT of a Patient-initiated Treatment Service for BEB and HFS | ||
| NCT02207946 | Botulinum Toxin A to Treat Arm Tremor | ||
| NCT05585398 | A Study to Evaluate the Distribution of Botulinum Neurotoxin Type A Administered as Intradermal Injections, Comparing Different Doses, Concentrations, and Delivery Methods | ||
| NCT07473635 | Perineural Incobotulinumtoxin-A for Complex Regional Pain Syndrome - An Open-label Feasibility Study | ||
| NCT01392300 | Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke | ||
| NCT06381999 | Validity and Inter-rater Reliability for Early Recognition of Spasticity Using the Decision Tree Tool | ||
| NCT01893411 | Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Leg(s) in Cerebral Palsy | ||
| NCT03992404 | Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury | ||
| NCT03806933 | Study to Investigate the Safety and Duration of Effect of Different Botulinum Toxin A (NT 201) Dose Groups Following the Treatment of Glabellar Frown Lines | ||
| NCT07486830 | IncobotulinumtoxinA for Provoked Vestibulodynia With Overactive Pelvic Floor Muscle Dysfunction | ||
| NCT04908423 | Xeomin® and Gait Related Mobility After Stroke | ||
| NCT01098019 | Treatment of Notalgia Paresthetica With Xeomin | ||
| NCT00909883 | Foot Dystonia Treatment by Botulinum Toxin Injections in Parkinson Disease : Efficiency of Injections Made in Extrinsic Muscle (Flexor Digitorum Longus Muscle) Compared to Intrinsic Muscle (Flexor Digitorum Brevis or Quadratus Plantae Muscles) | ||
| NCT02462317 | Study of the Effects on Motor Recovery of Early Post-stroke Spasticity Treatment | ||
| NCT04766723 | A Study to Investigate the Efficacy and Safety of NT 201 (Botulinum Toxin) Compared With Placebo for the Treatment of Adult Participants With Essential Tremor in the Arm | ||
| NCT00465738 | IncobotulinumtoxinA (Xeomin) for Upper Limb Spasticity | ||
| NCT00777803 | NT 201 (Xeomin®/Bocouture®) in Comparison With Clostridium Botulinum Toxin Type A in the Treatment of Glabellar Frown Lines | ||
| NCT00770029 | IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines No. 2 | ||
| NCT00955760 | Study Analyzing the Effect of Rifampicin Administration on the Pharmacokinetics of Neramexane Mesylate | ||
| NCT07018713 | A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine | ||
| NCT01109680 | A Single Center, Open-Label Study to Quantify Metabolites of [14C]-Neramexane in Plasma and Urine in Healthy Male Subjects | ||
| NCT00739635 | Efficacy, Safety and Tolerability of Neramexane in Patients With Subjective Tinnitus | ||
| NCT03650387 | Safety, Effectiveness and Participant Satisfaction Study of a Dermal Filler (of RADIESSE® (+) Lidocaine) in the Treatment of Ageing Signs in the Face | ||
| NCT04622254 | Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Crows Feet) in Subjects With Moderate to Severe Upper Facial Lines | ||
| NCT05327972 | DEgenerative ROtator Cuff Disease and Botulinum TOXin | ||
| NCT00649220 | Memantine and Antipsychotics Use | ||
| NCT04594213 | Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Lateral Canthal Lines) in Subjects With Moderate to Severe Upper Facial Lines | ||
| NCT00661440 | Efficacy and Safety Study of Neramexane to Treat Congenital and Acquired Nystagmus | ||
| NCT01261741 | Investigation of Memantine in the Treatment of Memory, Concentration or Attention Problems | ||
| NCT01565395 | Incobotulinum Toxin A for Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS) | ||
| NCT07018700 | A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine | ||
| NCT01905683 | Long-term Open-label Study of Botulinumtoxin Type A to Treat Spasticity of Leg(s) or Leg(s) and Arm in Cerebral Palsy | ||
| NCT00827008 | Open-Label, Long-Term Treatment Study, to Assess the Long-Term Safety and Tolerability and Efficacy of Neramexane in Patients With Subjective Tinnitus | ||
| NCT00915174 | Study to Evaluate the Effects of Neramexane on the Pharmacokinetics of a Combined Drospirenone/Ethinyl Estradiol Oral Contraceptive in Healthy Female Subjects | ||
| NCT00773591 | Effect of NT 201 (Botulinum Neurotoxin Type A Free of Complexing Proteins) on Sleep-related Breathing Disorders | ||
| NCT03256942 | Evaluation of the Sensitivity of Merz Lips Fullness Assessment Scale Following Etermis 4® Treatment for Lips Volume Augmentation | ||
| NCT01896895 | Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Abnormal Contraction or Twitch of the Eyelid | ||
| NCT07797790 | Real-world Patient Experiences With Inbrija® | ||
| NCT06091020 | A Clinical Trial to Investigate Efficacy and Safety of NT 201 Injections Compared With Placebo Injections in Participants Aged 18 Years and Older With Chronic Nerve Pain After Shingles or Nerve Injury | ||
| NCT00541723 | Efficacy and Safety of NT 201 in the Treatment of Lateral Periorbital Wrinkles | ||
| NCT02188277 | Treatment With Xeomin Versus Botox in Children With Spastic Equine and Equinovarus Foot Deformation in Pediatric Cerebral Palsy | ||
| NCT02002884 | Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Arm(s) or of Arm(s) and Leg(s) in Cerebral Palsy | ||
| NCT00936026 | Open, Single Center, Three Periods, Fixed Sequence Design Study on the Effects of Clopidogrel Co-administration on the Pharmacokinetics of Neramexane | ||
| NCT01305187 | Non-inferiority of Belotero® Basic Versus Juvéderm® Ultra 3 | ||
| NCT03119948 | Partial Blocks of Rectus Femoris and Soleus With Botulinum Toxin Type A (Xeomin®) to Improve Gait in Hemiparesis | ||
| NCT00770211 | IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines | ||
| NCT00978614 | Evaluation of Dose-Dependent Repeated-Dose Neramexane Effects on Cardiac Repolarisation (QT/QTc Interval Duration): Electrocardiogram (ECG) Study in Healthy Adult Subjects |
